KRYSTAL WREN: Open Payments
NPI 1417731548 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 25 payments from 9 companies in 2025. Trend: 2023 $15 · 2024 $345 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $144 |
| Lilly USA, LLC | 4 | $61 |
| Corcept Therapeutics | 3 | $61 |
| Averitas Pharma Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Medtronic, Inc. | 1 | $16 |
Products named: QULIPTA, Korlym, QUTENZA, MOUNJARO, UBRELVY, FARXIGA, EVENITY, The Cologuard Plus Collection Kit.
Industry payments across MS — which companies pay providers there.
